Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for iBio (IBIO) over the last 11 years, with Q4 2025 value amounting to $228000.0.

  • iBio's Other Non-Current Assets rose 224.22% to $228000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $228000.0, marking a year-over-year increase of 224.22%. This contributed to the annual value of $210000.0 for FY2025, which is 232.56% down from last year.
  • Latest data reveals that iBio reported Other Non-Current Assets of $228000.0 as of Q4 2025, which was up 224.22% from $228000.0 recorded in Q3 2025.
  • iBio's Other Non-Current Assets' 5-year high stood at $37.3 million during Q2 2022, with a 5-year trough of $24000.0 in Q1 2021.
  • In the last 5 years, iBio's Other Non-Current Assets had a median value of $276500.0 in 2022 and averaged $3.4 million.
  • Per our database at Business Quant, iBio's Other Non-Current Assets skyrocketed by 15537500.0% in 2022 and then tumbled by 9932.2% in 2023.
  • iBio's Other Non-Current Assets (Quarter) stood at $5.9 million in 2021, then crashed by 94.95% to $300000.0 in 2022, then soared by 333.33% to $1.3 million in 2023, then tumbled by 82.85% to $223000.0 in 2024, then rose by 2.24% to $228000.0 in 2025.
  • Its last three reported values are $228000.0 in Q4 2025, $228000.0 for Q3 2025, and $210000.0 during Q2 2025.